Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
, 22 (3), 251-8

Maxillary Sinus Floor Elevation With Bovine Bone Mineral Combined With Either Autogenous Bone or Autogenous Stem Cells: A Prospective Randomized Clinical Trial

Affiliations
Randomized Controlled Trial

Maxillary Sinus Floor Elevation With Bovine Bone Mineral Combined With Either Autogenous Bone or Autogenous Stem Cells: A Prospective Randomized Clinical Trial

D Rickert et al. Clin Oral Implants Res.

Erratum in

  • Clin Oral Implants Res. 2011 Jul;22(7):777
  • Corrigendum.
    Clin Oral Implants Res. 2011 Jul;22(7):777. doi: 10.1111/j.1600-0501.2011.02229.x. Clin Oral Implants Res. 2011. PMID: 29768910 No abstract available.

Abstract

Aim: To assess whether differences occur in bone formation after maxillary sinus floor elevation surgery with bovine bone mineral (BioOss(®)) mixed with autogenous bone or autogenous stem cells. The primary endpoint was the percentage of new bone three months after the elevation procedure.

Material and methods: In a randomized, controlled split-mouth design, in 12 consecutive patients (age 60.8 ± 5.9 years, range 48-69 years) needing reconstruction of their atrophic maxilla, a bilateral sinus floor augmentation procedure was performed. Randomly, on one side the augmentation procedure was performed with bovine bone mineral (BioOss(®)) seeded with mononuclear stem cells harvested from the posterior iliac crest (test group) while BioOss(®) mixed with autogenous bone (harvested from the retromolar area) was applied on the contra-lateral side (control group). On 14.8 ± 0.7 weeks after the sinus floor elevation, biopsies from the reconstructed areas were taken at the spots where subsequently the endosseous implants were placed. The biopsies were histomorphometrically analyzed.

Results: Significantly more bone formation was observed in the test group (17.7 ± 7.3%) when compared with the control group (12.0%± 6.6; P=0.026). In both the test and control group, all implants could be placed with primary stability. In one patient, not all biopsies contained BioOss(®). This patient was excluded from analysis.

Conclusion: Mesenchymal stem cells seeded on BioOss(®) particles can induce the formation of a sufficient volume of new bone to enable the reliable placement of implants within a time frame comparable with that of applying either solely autogenous bone or a mixture of autogenous bone and BioOss(®). This technique could be an alternative to using autografts.

Similar articles

See all similar articles

Cited by 23 articles

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

Feedback